2024-11-18 00:35:49
OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors
Health/ 2023-08-16
OnCusp Therapeutics Receives FDA Clearan...

NEW YORK,Aug. 15,2023--OnCusp Therapeutics,a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into cl...

Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis
Health/ 2023-08-16
Inmagene's OX40 mAb, with an extend...

SAN DIEGO,SHANGHAI and SYDNEY,Aug. 15,2023--Inmagene Biopharmaceuticals ("Inmagene"),a clinical stage biotechnology company develo...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release